Last Updated: June 8, 2026

Profiles for companies starting with 'b'


✉ Email this page to a colleague

« Back to Dashboard


Drugs and US Patents for b

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim JENTADUETO linagliptin; metformin hydrochloride TABLET;ORAL 201281-003 Jan 30, 2012 AB RX Yes Yes 10,022,379*PED ⤷  Start Trial Y ⤷  Start Trial
Boehringer Ingelheim SYNJARDY XR empagliflozin; metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 208658-001 Dec 9, 2016 RX Yes No 9,949,998*PED ⤷  Start Trial Y ⤷  Start Trial
Barr Labs Inc NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL ethinyl estradiol; norethindrone acetate TABLET;ORAL 076221-001 Nov 6, 2009 AB RX No Yes ⤷  Start Trial ⤷  Start Trial
Biocon Pharma LIOTHYRONINE SODIUM liothyronine sodium TABLET;ORAL 218070-002 Feb 6, 2024 AB RX No No ⤷  Start Trial ⤷  Start Trial
Biocryst ORLADEYO berotralstat dihydrochloride CAPSULE;ORAL 214094-001 Dec 3, 2020 RX Yes No 12,545,646*PED ⤷  Start Trial Y ⤷  Start Trial
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-005 May 24, 1999 DISCN No No ⤷  Start Trial ⤷  Start Trial
Boehringer Ingelheim MIRAPEX ER pramipexole dihydrochloride TABLET, EXTENDED RELEASE;ORAL 022421-002 Feb 19, 2010 DISCN Yes No 7,695,734 ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.